ELEV
Barclays’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,538
| Closed | -$16K | – | 4397 |
|
|
2025
Q1 | $16K | Sell |
59,538
-28,070
| -32% | -$7.54K | ﹤0.01% | 4087 |
|
|
2024
Q4 | $49K | Buy |
87,608
+15,531
| +22% | +$8.69K | ﹤0.01% | 3959 |
|
|
2024
Q3 | $43K | Buy |
72,077
+54,167
| +302% | +$32.3K | ﹤0.01% | 3950 |
|
|
2024
Q2 | $49K | Buy |
+17,910
| New | +$49K | ﹤0.01% | 3685 |
|
|
2023
Q4 | – | Sell |
-18,350
| Closed | -$12K | – | 4231 |
|
|
2023
Q3 | $12K | Buy |
+18,350
| New | +$12K | ﹤0.01% | 3996 |
|
|
2023
Q1 | – | Sell |
-392
| Closed | – | – | 4327 |
|
|
2022
Q4 | $0 | Hold |
392
| – | – | ﹤0.01% | 4411 |
|
|
2022
Q3 | $0 | Hold |
392
| – | – | ﹤0.01% | 4691 |
|
|
2022
Q2 | $1K | Hold |
392
| – | – | ﹤0.01% | 4620 |
|
|
2022
Q1 | $1K | Buy |
+392
| New | +$1K | ﹤0.01% | 4704 |
|